Jason LaTorre

Legislation, regulation, policies, and programs concerning the federal government’s future pandemic preparedness and personal protective equipment supply chain management. Activities around amending the Hazardous Product Regulations (HPR), VOC, and Pest Control acts. Confidential Business Information to harmonize with other jurisdictions. The creation of tax reform to support Canadian manufacturers Technology improvements and processes for Defence procurement programs including soldier safety, Shipbuilding, Aerospace technology and Army Equipment. Addressing proposals surrounding tariffs and trade policy Recommendations for policies addressing labour shortages in skilled trades,supporting STEM education and training, and worker safety S-5 An Act to Amend the Canadian Environmental Protection Act and other Acts. Respecting proposed changes to the assessment and management of Chemicals and Products; the creation of a 'Watch List' for chemical substances; and the protection of confidential business information. National Shipbuilding Strategy Programs with respect to technology around advanced materials Legislation and regulation with respect to the creation of a plastics registry, plastic labelling or recycled content for plastic products. GHG reduction measures, in respect to the Clean Fuel Standard, Carbon Pricing, Out-Based Pricing System and other GHG reduction policies and regulations. Chemicals Management Plan under Environmental Protection Act 1999 regarding the review of substances, which may be used in consumer products. Canadian Chemical Management Plan under Environmental Protection Act 1999, with respect to schedule 1 of the act. Interact with Health and Environment and Climate Change Canada for impacted reviewed Chemicals as appropriate. Canada's Implementation of the Globally Harmonized System of Classifications and Labelling of Chemicals mainly as it relates to regulatory and implementation alignment with the US Budget recommendations in respect to use of tax relief and fiscal incentives to drive meaningful innovation and promote commercialization Budget recommendations in respect of creating a federal innovation agenda with tools aimed at enhancing Canadian industry performance Budget recommendations in respect of developing a Climate Change policy in a manner promoting innovation and economic development Budget recommendations in respect of reducing impediments to trade and flow of people Better alignment of regulatory requirements between Canada and US to streamline regulatory approvals and avoid duplication.

To engage and advocate for the economic and social benefits of mining to the Canadian economy, including Indigenous economic reconciliation, with investment-friendly policies regarding regulatory system, support for decarbonization, skills training and critical mineral development. To raise awareness with government officials with respect to the Company's development plans for new mining projects in Nunavut, including employment and training, opportunities and benefits for Inuit people and communities, the Company’s consultation and environmental management programs, and additional environmental sustainability opportunities in line with government and Inuit priorities and policies. To raise awareness with government officials with respect to the Company's development plans for mining projects in Ontario and Quebec, including employment and training, opportunities and benefits for Indigenous peoples and local communities, and the Company’s consultation and environmental management programs. To raise awareness with government officials and departments on the need for major infrastructure investment in the Arctic, including high speed internet infrastructure in Nunavut to support industry and community needs and enhance opportunities and economic linkages. To engage and raise awareness with government officials and departments on the need for clean energy infrastructure development in the Kivalliq and Kitikmeot regions of Nunavut. Energy alternatives will significantly reduce the need to rely 100% on diesel generation as the only source of energy in these areas, significantly reducing GHG emissions and improving economic development opportunity for communities and industry.

Work with government to promote and support Canada’s digital economy, including ensuring the availability of a high-skilled tech workforce. Work with government to facilitate the process of selling goods and services online, and delivering them to consumers.

Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Food and Drug regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canada's Drug Agency (CDA) policies as it relates to health economics assessment and recommendations made on new medicines. Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Free Trade agreements as they relate to the biopharmaceutical industry Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19. Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution. Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.

Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time to reimbursement and streamline federal/provincial listing processes. Discussion focused on sharing perspectives on priorities and resourcing. In particular, a shared observation of an increase in submission reviews exceeding established timeframes and increasing challenges with securing pre-filing meetings were discussed Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility". Merck is seeking to ensure Canada's continued compliance with its obligations under TRIPs relevant to the biopharmaceutical industry within all domestic legislation in addition to ongoing and future trade negotiations. Relevant domestic legislation includes the Food and Drugs Act, the Patent Act, and related regulations and guidance documents. Beyond TRIPs, Merck is seeking enhancements to increase the stability and global competitiveness of Canada’s intellectual Property legislation, regulations and policies relevant to the biopharmaceutical industry. Such enhancements may result from domestic policy in addition to bilateral and multilateral trade negotiations (e.g. Comprehensive Economic and Trade Agreement (CETA) and the Trans-Pacific Partnership (TPP). World Health Organization issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernment Working Group (IGWG). US - Canada Regulatory Cooperation Council (RCC) as it relates to the regulation of biopharmaceutical products. The government's Science and Technology strategy as it relates to the biopharmaceutical industry. Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations. Smart Regulations as it relates to the biopharmaceutical industry. Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits. Policies and programs as it relates to vaccine approval, procurement and public awareness of immunization. Plan design and reimbursement policies for drug plans administered by Federal Government including NIHB and Corrections Services. Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) and R&D reporting. Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products. Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive. Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products. Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products. Partnership opportunities as it relates to Canada's policy and programs to improve health in the developing world, such as Maternal and Child Health. New Substances Notification Regulations as it relates to the biopharmaceutical industry. National Pharmaceutical Strategy as it relates to the federal government's involvement in federal/provincial access to medicines framework. Income Tax Act as it relates to biopharmaceutical products. Health Canada's Legislative and Regulatory Modernization (LRM) as it relates to the review, approval, transparency and compliance activities of biopharm

Northvolt is a supplier of sustainable, high-quality lithium-ionbattery cells and systems. Northvolt is on a mission to producethe world's greenest battery cell by utilizing fossil-free energy,circular production and the highest ambitions for recycling.Northvolt is exploring the opportunity to build and operate batteryproduction in North America (design, development and productionof batteries), and is therefore in dialogue with the federalGovernment in order to identify potential policy, regulatory andfinancial support that would enable potential expansion plans.

Providing updates and engagement in discussion surrounding the KSM (Kerr-Sulphurets-Mitchell) Project and its current status.

Representations, comments and discussions regarding North American and international energy security, the integration of pipeline infrastructure and promotion of energy exports. Discussions include impacts on international trade and imposition of tariffs. Representations, comments and discussions on policies and regulations which encourage economic investment, job creation and pipeline capacity in Canada. Discussions regarding Canada’s competitiveness, including with respect to taxation, access to capital and taxation. Discussions regarding Indigenous engagement, consultation and partnerships. Communications regarding pipeline related matters and energy projects, such as project review timelines, pipeline safety and incident response and safety improvements.

Work with the Government of Canada on international engagements as it relates to the digital economy and Internet connectivity. Work with government to promote and support Canada's digital economy, specifically in regards to advancing rural broadband. Work with Government of Canada to promote and support Canada's space economy Providing input to discussions or proceedings regarding support for expansion of broadband service to rural areas. Providing industry input to the Government on the Canadian Space Agency regarding the future of the Agency. Provide input to Innovation, Science and Economic Development Canada regarding spectrum and orbital slot allocation procedures, as well as spectrum fees. Engage with the Strategic Innovation Fund regarding communication technologies. Engage with the government of Canada on funding programs aimed at advancing the deployment of rural broadband Engage with the government of Canada on federal funding programs aimed at supporting communication technologies. Engage in discussions with the Government of Canada on the creation of a National Space Council Encourage the Government of Canada to fulfill unique communications, scientific or military requirements through new satellite programs Discussions with the Government of Canada on immigration as it relates to attracting and retaining a highly skilled workforce Changes to the regulatory fees charged by government for spectrum and orbital slots